Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 39.61
+0.71 (1.83%)
Oct 14, 2026, 10:00 AM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.8 billion as of October 13, 2026. It is the 11,316th most valuable company in the world and the 2,721st biggest in China. Its market cap has decreased by 4.16% in one year.
Market Cap
5.80B
Enterprise Value
4.63B
Revenue
459.42M
Global Rank
Country Rank
#2,721 China
PE Ratio
252.03
ChartMarket Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.80B, a decrease of -29.55%. That is a compound annual growth rate of -6.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 5.80B | 4.84% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Ausun Pharmaceutical | 6.76B |
| Jiangsu Aidea Pharmaceutical Group | 6.63B |
| PharmaResources (Shanghai) | 6.53B |
| Youcare Pharmaceutical Group | 5.95B |
| R&G PharmaStudies | 5.95B |
| Wuhan Keqian Biology Co.,Ltd | 5.76B |
| Shanghai Obio Technology (Group) Corp. | 5.41B |
| Boji Medical Technology | 5.41B |